These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22438466)

  • 1. Most important papers in health costs, cost-effectiveness, and resource utilization.
    Dharmarajan K; Lampropulos J; Bikdeli B; Mody P; Gupta A
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):e9-15. PubMed ID: 22438466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most important outcomes research papers in cardiovascular disease in the elderly.
    Gupta A; Mody P; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):e17-26. PubMed ID: 22592757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most important outcomes research papers on anticoagulation for cardiovascular disease.
    Bikdeli B; Gupta A; Mody P; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e65-74. PubMed ID: 22991352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most important articles on cardiovascular disease among racial and ethnic minorities.
    Mody P; Gupta A; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):e33-41. PubMed ID: 22811508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most important outcomes research papers on treatment of stable coronary artery disease.
    Bikdeli B; Ranasinghe I; Chen R; Gupta A; Lampropulos JF; Kulkarni VT; Mody PS; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):e17-25. PubMed ID: 23674308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most important outcomes research papers on hypertension.
    Chen R; Dharmarajan K; Kulkarni VT; Punnanithinont N; Gupta A; Bikdeli B; Mody PS; Ranasinghe I
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):e26-35. PubMed ID: 23838106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resource utilization system for cost allocation in invasive cardiology.
    Davis SH; O'Donnell TK; Cabage BA
    J Cardiovasc Manag; 1997; 8(2):17-26. PubMed ID: 10166015
    [No Abstract]   [Full Text] [Related]  

  • 8. The economics of cardiovascular disease in the United States.
    Chen J; Rizzo JA
    Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using databases for studying and comparing health care costs and resource use.
    Melfi CA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):399-402. PubMed ID: 11802584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is resternotomy in cardiac surgery still a problem?
    Morales D; Williams E; John R
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):277-86. PubMed ID: 20525761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization and disability outcome assessment of combat casualties from Operation Iraqi Freedom and Operation Enduring Freedom.
    Masini BD; Waterman SM; Wenke JC; Owens BD; Hsu JR; Ficke JR
    J Orthop Trauma; 2009 Apr; 23(4):261-6. PubMed ID: 19318869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuity of care: is it cost effective?
    Raddish M; Horn SD; Sharkey PD
    Am J Manag Care; 1999 Jun; 5(6):727-34. PubMed ID: 10538452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
    Shah M; Butler M; Bramley T; Curtice TG; Fine S
    Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
    Gaziano TA
    Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
    Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.